Raising the Bar for Dietary Supplement Clinical Trials

February 15, 2012

1 Min Read
Raising the Bar for Dietary Supplement Clinical Trials

Double blind, randomized controlled trials (DBRCTs) are generally perceived to be the gold standard for clinical trials. While DBRCTs clearly can produce high-quality data, it is important to question the quality of the trial design, trial conduct clinical data management, statistical analysis and interpretation.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like